Microdosing involves the off-label use of GLP-1 medications (semaglutide and tirzepatide) at much smaller doses than the standard recommended dose, such as: Consuming a fraction of a starter dose, such as 0.05 mg of Ozempic instead of 0.25 mg
for some [dulaglutide (Gerstein et al., 2019), liraglutide (Marso et al., 2016) and semaglutide (Marso et al., 2017)], the CVOTs also confirmed a cardiovascular benefit and eventually led to the approved use of these GLP-1 RAs to reduce cardiovascular risk in people with type 2 diabetes and established CVD or at high cardiovascular risk (Honigberg et al., 2020)
If your pharmacy uses a different concentration, the units per dose will shift
They are not licensed by any state board
Exenatide was found to lower the levels of high sensitivity-C-reactive protein and endothelin-1 in comparison to glargine insulin in another study [63]
After adjustment of the model for weight loss, associations between the groups and headache outcomes did not remain statistically significant although a trend towards better headache outcomes in the GLP-1-RA group was noted
